# Novonesis

> Novonesis is a Danish biotech giant, formed in 2024 from the merger of enzyme maker Novozymes and cultures specialist Chr. Hansen. It sells enzymes, microbes and probiotics to more than 30 industries - the invisible ingredients that make bread rise, laundry clean in cold water, cows digest feed and biofuel ferment. With roughly 11,000 employees and about EUR 3.7 billion in annual sales, it is the largest player in industrial biosolutions.

- **Founded:** 2024
- **Headquarters:** Bagsvaerd (Kongens Lyngby), Denmark
- **Founders:** Christian D. A. Hansen (Founder of Chr. Hansen (1874))
- **Team size:** Approximately 11,000 employees
- **Products:** Industrial enzymes, Microbial cultures, Probiotics and human health biosolutions, Animal and plant nutrition, Bioenergy solutions
- **Notable:** Completed the merger of Novozymes and Chr. Hansen in January 2024 to form Novonesis, a leading global biosolutions company., Holds an estimated ~50% market share in industrial enzymes and microbial solutions., Maintains a library of roughly 50,000 microbial strains and more than 10,000 patents.

## Products & services

- **Industrial enzymes** — Enzyme solutions for detergents, baking, brewing, textiles, starch and biofuel that cut chemicals, energy and water use.
- **Microbial cultures** — Cultures for dairy, cheese, fermented foods and plant-based products, including the fermentation strains behind yogurt and cheese.
- **Probiotics and human health biosolutions** — Probiotics, postbiotics, synbiotics and human milk oligosaccharides (HMOs), including the widely documented BB-12 Bifidobacterium strain.
- **Animal and plant nutrition** — Feed enzymes, silage inoculants and microbial solutions for soil health, plant health and crop yield, including biological nitrogen fixation.
- **Bioenergy solutions** — Enzymes for ethanol, biodiesel, renewable diesel and biogas production.
- **Household care biosolutions** — Enzymes and microbes for laundry, dishwashing and surface cleaning that work at lower temperatures.

## Achievements

- Completed the merger of Novozymes and Chr. Hansen in January 2024 to form Novonesis, a leading global biosolutions company.
- Holds an estimated ~50% market share in industrial enzymes and microbial solutions.
- Maintains a library of roughly 50,000 microbial strains and more than 10,000 patents.
- Serves more than 30 industries with biological alternatives to chemical processes.
- Reported 8% organic pro forma sales growth for 2024, the group's first full year.

## Latest updates

- **2024-01** — Novozymes and Chr. Hansen complete their combination, officially forming Novonesis.
- **2025-02** — Reports 2024 full-year results with 8% organic pro forma sales growth.
- **2025-08** — Publishes H1 2025 interim report.
- **2026-04** — Reports Q1 2026 results with 7% organic sales growth and a 37.8% adjusted EBITDA margin.

## Links

- Website: https://novonesis.com
- LinkedIn: https://www.linkedin.com/company/novonesis
- Twitter/X: https://twitter.com/Novozymes
- YouTube: https://www.youtube.com/channel/UCBxQKR039g69sbRh_Cx_HEg
- Instagram: https://www.instagram.com/novozymes/
- Facebook: https://www.facebook.com/novonesisbio

---

Profile page: https://yespress.io/novonesis
Published by YesPress — https://yespress.io
Last updated: 2026-08-13